CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

New data on Cladribine Tablets presented at AAN annual meeting

EMD Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that new data providing further understanding on Cladribine Tablets as a potential new therapeutic option for relapsing forms of multiple sclerosis were presented at the 62nd Annual Meeting of the American Academy of Neurology.

17 Apr 2010

New cardiac CT technology promises low radiation exposure and improved image quality

Cardiovascular disease is the leading cause of death globally and a tremendous burden on the healthcare system. Better detection of hardening or clogging of arteries and other blood vessels before symptoms occur is needed.

15 Apr 2010

Florida to enact health care legislation to improve access to ARV therapy

Florida is poised to enact health care legislation that would add clarity to existing state statutes by requiring that all state-regulated health plans include lifesaving antiretroviral (ARV) HIV/AIDS drugs on their drug formularies or preferred drug lists.

15 Apr 2010

New CZT-based cardiac nuclear imaging system now at Mount Sinai Medical Center

The Mount Sinai Medical Center has become the first in the United States to commercially use a new cardiac nuclear imaging system by GE Healthcare, a cadmium zinc telluride (CZT)-based high-speed, high-resolution camera that drastically reduces imaging time for patients while also reducing radiation exposure compared to previously used technologies.

12 Apr 2010

Clarian Health Partners selects MedVentive as technology partner

Clarian Health Partners, Indiana's largest healthcare system, has selected MedVentive as a technology partner for its clinically-integrated network, Clarian Quality Partners.

9 Apr 2010

Biosense Webster obtains first Ethics Committee approval for CLARITY study

Biosense Webster announces that this week it has obtained its first Ethics Committee approval for the CLARITY study, comparing the 1-year efficacy, safety and efficiency of CARTO(R) 3 System-guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) Catheter versus fluoroscopy-guided radiofrequency ablation using the Pulmonary Vein Ablation Catheter(R) (PVAC(R), Ablation Frontiers, Medtronic) in patients with paroxysmal atrial fibrillation.

9 Apr 2010

MHS to deploy NextGen EHR and NextGen HIE management solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Mercy Health System to deploy NextGen® EHR and NextGensm Health Information Exchange.

6 Apr 2010

New technique could allow pilots to peer through fog and doctors to see more precisely into the human body

A new technique for revealing images of hidden objects may one day allow pilots to peer through fog and doctors to see more precisely into the human body without surgery.

3 Apr 2010

Pfizer shares details of financial relationships with U.S. healthcare professionals and researchers

Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.

2 Apr 2010

Americans looking more closely at health-care reform

Health care is on the minds of most Americans today. And according to Euro RSCG Worldwide's Spring 2010 "U.S. Mind and Mood Report," 67.6 percent of men and 61.5 percent of women are more interested in the subject than they were during the previous 12 to 18 months.

1 Apr 2010

Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple sclerosis portfolio of approved and investigational treatments will be presented at the 62nd Annual Meeting of the American Academy of Neurology taking place April 10 to 17, in Toronto, Canada.

1 Apr 2010

Repros Therapeutics announces response to FDA critique on proposed Phase II Androxal study

Repros Therapeutics Inc. today announced that the Company is sending a reply to the FDA's Division of Metabolism and Endocrinology Products following the Company's receipt of FDA's comments on the proposed Phase II study of Androxal® (enclomiphene) in the treatment of Type II diabetes under Repros' open IND. On February 2, 2010 the Company announced that Repros received confirmation from the Agency that the new IND is effective.

1 Apr 2010

Facts and treatment options for endometriosis

One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to research from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley.

31 Mar 2010

iPhone can provide valuable assistance to insurance holders

Mobile devices such as the iPhone can provide valuable assistance to insurance holders in a claims situation, comparison site Constructaquote.com has said.

29 Mar 2010

New CONSORT statement to improve reporting of trial findings published

New guidance to improve the reporting of trial findings is published simultaneously today (24 March 2010) by PLoS Medicine and eight other leading journals around the world, BMJ, The Lancet, Obstetrics & Gynecology, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

26 Mar 2010

FDA approves Riverain Medical's Softview Enhanced Chest Imaging technology

Riverain Medical, a leading image enhancement and computer-aided detection company dedicated to providing physicians with tools to assist in image interpretation, announced today that the U.S. Food and Drug Administration (FDA) has cleared the SoftView Enhanced Chest Imaging technology.

25 Mar 2010

Nabi Biopharmaceuticals expands share repurchase program to enhance shareholder value

Nabi Biopharmaceuticals announced today that its Board of Directors has approved an aggregate total of up to $60.9 million to repurchase the Company's outstanding common shares in the open market or in privately negotiated transactions.

24 Mar 2010

First Edition: March 22, 2010

Today's headlines detail yesterday's historic House vote on health reform while also looking forward to how action might play out in the Senate, how the legislative package impacts the current political dynamic and what its effects will be on consumers and stakeholders.

22 Mar 2010

Surgeon General to outline priorities at PCPCC Stakeholder's Summit

Surgeon General Regina Benjamin, MD, knows first-hand the connection doctors and patients need in order to address tough chronic health threats. Benjamin will discuss her priorities as Surgeon General in a keynote address at the Stakeholder's Summit of the Patient-Centered Primary Care Collaborative (PCPCC) at 10 a.m. on March 30 in Washington, DC.

22 Mar 2010

The Purpose Institute to support Healthways' Vitality Quest initiative

Healthways, Inc., a Founding Member of The Purpose Institute, announced today that that the Institute has been engaged to support the Company’s recently announced Vitality QuestSM initiative to help communities committed to the health, well-being and productivity of their citizens become Healthways-Blue Zones Vitality CitiesSM

22 Mar 2010